Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status.

Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status.

<h4>Background</h4>Uterine Carcinosarcomas (UCS) are a rare type of cancer composed of an admixture of high-grade carcinomatous and sarcomatous elements. Clinicopathological prognostic factors in UCS are well established, but studies that approach the impact of biomarkers in this unusual...

Full description

Bibliographic Details
Main Authors:	Jesse Lopes da Silva, Lucas Zanetti de Albuquerque, Fabiana Resende Rodrigues, Nina Carrossini Bastos, Isabele Avila Small, Elisa Bouret Campos Barroso, Fernando Lopes Cordero, Daniel de Souza Fernandes, Eduardo Paulino, Andreia Cristina de Melo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0285447

Similar Items

MLH1 promoter hypermethylation in uterine carcinosarcoma rarely coexists with TP53 mutation
by: Michal Kunc, et al.
Published: (2019-11-01)

Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas
by: Evelin Makk, et al.
Published: (2023-12-01)

Uterine Carcinosarcoma in a Patient with Didelphys Uterus
by: C. Iavazzo, et al.
Published: (2013-01-01)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
by: Giorgia Lodetti, et al.
Published: (2023-07-01)

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas
by: İrfan Cicin, et al.
Published: (2016-10-01)

Uterine Carcinosarcoma: A Case Report and Literature Review
by: Ali Kord, et al.
Published: (2020-01-01)

Cutaneous metastasis of uterine carcinosarcoma mimicking drug eruption
by: Katherine L. Wang, BS, et al.
Published: (2024-05-01)

Clostridium and Bacteroides bacteremia as initial presentation of uterine carcinosarcoma
by: Chinonye S. Imo, et al.
Published: (2022-08-01)

Transcriptome of sessile serrated adenoma/polyps is associated with MSI‐high colorectal cancer and decreased expression of CDX2
by: Daisuke Ohki, et al.
Published: (2022-12-01)

Uterine carcinosarcoma with microsatellite instability - does immunotherapy modify the therapeutic scenario? A case report and literature review
by: Diocesio Alves Pinto Andrade, et al.
Published: (2023-09-01)

Uterine Sarcoma and Carcinosarcoma: A Two-Center Experience in Iran
by: Sare Hosseini, et al.
Published: (2024-07-01)

Survival analysis of patients with rare tumors of the uterine corpus – carcinosarcoma
by: Stevanović Nemanja, et al.
Published: (2024-01-01)

Management and Prognosis of Patients with Recurrent or Persistent/Progressive Uterine Carcinosarcoma
by: Hsiu-Jung Tung, et al.
Published: (2022-10-01)

Pure abscopal effect in a patient with advanced uterine carcinosarcoma
by: Kazuhiro Okamoto, MD, et al.
Published: (2023-07-01)

Uterine carcinosarcoma: A 10-year single institution experience.
by: Leana Terblanche, et al.
Published: (2022-01-01)

CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
by: Pina Ziranu, et al.
Published: (2023-03-01)

The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma
by: Risako Ozawa, et al.
Published: (2024-10-01)

Non-islet cell tumor hypoglycemia in a patient with uterine carcinosarcoma
by: Miller P. Singleton, et al.
Published: (2022-02-01)

Uterine cervical carcinosarcoma; very rare and aggressive behavior; literature review
by: Özer Birge, et al.
Published: (2021-04-01)

Clinically aggressive “low-grade” uterine carcinosarcoma: A case report
by: Theresa Clearman, et al.
Published: (2015-11-01)

The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study
by: Leonardo Tomiatti da Costa, et al.

Quality of life and survival in patients with uterine carcinosarcoma: A tertiary center observational study
by: Eveline N.B. Pham, et al.
Published: (2025-02-01)

An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature
by: C. Ebner, et al.
Published: (2024-08-01)

Gemcitabine combination therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids
by: Matías J. Dahl, et al.
Published: (2024-03-01)

Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma
by: Xiaodan Chen, et al.
Published: (2024-02-01)

Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: A case report
by: Korhan Kahraman, et al.
Published: (2012-03-01)

Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma
by: Xue Fan, et al.
Published: (2023-01-01)

Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics study
by: Cheng-I Liao, et al.
Published: (2022-04-01)

Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma
by: Jing Li, et al.
Published: (2017-02-01)

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
by: Akihiko Wakayama, et al.
Published: (2017-08-01)

Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: A case report
by: Saki Sawayama, et al.
Published: (2022-06-01)

The Correlation of P53 and MSI Immune Markers in Gastric Adenocarcinoma
by: Ali M. Al-Shakarchi, et al.
Published: (2024-07-01)

AIFM1 is a prognostic biomarker for uterine carcinosarcoma and is associated with immune cell infiltration
by: Lijuan Wang, et al.
Published: (2025-02-01)

Non-Metastatic Uterine Carcinosarcoma: A Tailored Approach or One Size Fits All?
by: Hannah Maione, et al.
Published: (2024-06-01)

HER2 amplification in Uterine carcinosarcoma after tamoxifen therapy: a case report
by: Fuqiang Zheng, et al.
Published: (2023-12-01)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023-01-01)

Epithelial-mesenchymal transition in uterine carcinosarcoma from a dedifferentiated papillary serous carcinoma to a sarcoma: case report
by: Yago Eloy Souza Barbosa, et al.
Published: (2023-08-01)

The Sentinel 2 MSI Spectral Mixing Space
by: Christopher Small, et al.
Published: (2022-11-01)

Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes
by: Gurdial Dhillon, et al.
Published: (2024-08-01)

THYROID CARCINOSARCOMA
by: V. М. Perelmuter, et al.
Published: (2016-02-01)